4//SEC Filing
McMinn Rachel 4
Accession 0001144204-17-051412
CIK 0001270073other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 9:00 PM ET
Size
5.0 KB
Accession
0001144204-17-051412
Insider Transaction Report
Form 4
McMinn Rachel
Chief Strategy Officer
Transactions
- Sale
Common Stock
2017-10-02$58.89/sh−283$16,667→ 16,875 total
Footnotes (1)
- [F1]Each employee of the Issuer who has received restricted stock awards has agreed to a mandatory sale of a sufficient number of shares of common stock to cover his or her withholding tax amounts upon the vesting of such restricted stock awards. The sales denoted here were made pursuant to such agreement to cover withholding tax obligations of the employee.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001606302
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 9:00 PM ET
- Size
- 5.0 KB